Author profile
Thomas L. Perry Jr., MD
The November 2018 issue of the BCMJ included two articles about diabetes management in British Columbia and a guest editorial that referred to the Therapeutics Initiative (TI). We would like to respond to the... Read More
Drs Miller and Humphries[1] raise important issues regarding serious adverse events (SAEs) that merit further discussion, particularly in relation to our Therapeutics Letter #48, “Do statins have a role... Read More